253 related articles for article (PubMed ID: 38704475)
21. Designing a Multi-epitope Vaccine against the SARS-CoV-2 Variant based on an Immunoinformatics Approach.
Farhani I; Yamchi A; Madanchi H; Khazaei V; Behrouzikhah M; Abbasi H; Salehi M; Moradi N; Sanami S
Curr Comput Aided Drug Des; 2024; 20(3):274-290. PubMed ID: 37309762
[TBL] [Abstract][Full Text] [Related]
22. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
Jakhar R; Kaushik S; Gakhar SK
J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
[TBL] [Abstract][Full Text] [Related]
23. MERS virus spike protein HTL-epitopes selection and multi-epitope vaccine design using computational biology.
Joshi A; Akhtar N; Sharma NR; Kaushik V; Borkotoky S
J Biomol Struct Dyn; 2023; 41(22):12464-12479. PubMed ID: 36935104
[TBL] [Abstract][Full Text] [Related]
24. Tracking the pipeline: immunoinformatics and the COVID-19 vaccine design.
Rezaei S; Sefidbakht Y; Uskoković V
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34219142
[TBL] [Abstract][Full Text] [Related]
25. Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An
Dar HA; Waheed Y; Najmi MH; Ismail S; Hetta HF; Ali A; Muhammad K
J Immunol Res; 2020; 2020():8893483. PubMed ID: 33274246
[TBL] [Abstract][Full Text] [Related]
26. Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus.
Singh J; Malik D; Raina A
Vaccine; 2021 Feb; 39(7):1087-1095. PubMed ID: 33478787
[TBL] [Abstract][Full Text] [Related]
27. Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant.
Khan K; Khan SA; Jalal K; Ul-Haq Z; Uddin R
Virology; 2022 Jul; 572():28-43. PubMed ID: 35576833
[TBL] [Abstract][Full Text] [Related]
28. A conserved subunit vaccine designed against SARS-CoV-2 variants showed evidence in neutralizing the virus.
Kibria KMK; Faruque MO; Islam MSB; Ullah H; Mahmud S; Miah M; Saleh AA
Appl Microbiol Biotechnol; 2022 Jun; 106(11):4091-4114. PubMed ID: 35612630
[TBL] [Abstract][Full Text] [Related]
29. Immunoinformatics design of a novel epitope-based vaccine candidate against dengue virus.
Fadaka AO; Sibuyi NRS; Martin DR; Goboza M; Klein A; Madiehe AM; Meyer M
Sci Rep; 2021 Oct; 11(1):19707. PubMed ID: 34611250
[TBL] [Abstract][Full Text] [Related]
30. Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2.
Rahmani A; Baee M; Saleki K; Moradi S; Nouri HR
J Biomol Struct Dyn; 2022 Aug; 40(13):6097-6113. PubMed ID: 33509045
[TBL] [Abstract][Full Text] [Related]
31. Identification of HLA-A*24:02-Restricted CTL Candidate Epitopes Derived from the Nonstructural Polyprotein 1a of SARS-CoV-2 and Analysis of Their Conservation Using the Mutation Database of SARS-CoV-2 Variants.
Takagi A; Matsui M
Microbiol Spectr; 2021 Dec; 9(3):e0165921. PubMed ID: 34937174
[TBL] [Abstract][Full Text] [Related]
32. Immunoinformatics prediction of overlapping CD8
Fatoba AJ; Maharaj L; Adeleke VT; Okpeku M; Adeniyi AA; Adeleke MA
Vaccine; 2021 Feb; 39(7):1111-1121. PubMed ID: 33478794
[TBL] [Abstract][Full Text] [Related]
33. Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach.
Ahammad I; Lira SS
Int J Biol Macromol; 2020 Nov; 162():820-837. PubMed ID: 32599237
[TBL] [Abstract][Full Text] [Related]
34. Identification of Highly Conserved SARS-CoV-2 Antigenic Epitopes with Wide Coverage Using Reverse Vaccinology Approach.
Hisham Y; Ashhab Y; Hwang SH; Kim DE
Viruses; 2021 Apr; 13(5):. PubMed ID: 33925069
[TBL] [Abstract][Full Text] [Related]
35. Design of a multi-epitope-based vaccine consisted of immunodominant epitopes of structural proteins of SARS-CoV-2 using immunoinformatics approach.
Mahmoudvand S; Esmaeili Gouvarchin Ghaleh H; Jalilian FA; Farzanehpour M; Dorostkar R
Biotechnol Appl Biochem; 2023 Jun; 70(3):1189-1205. PubMed ID: 36577011
[TBL] [Abstract][Full Text] [Related]
36. Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach.
Mahmud S; Rafi MO; Paul GK; Promi MM; Shimu MSS; Biswas S; Emran TB; Dhama K; Alyami SA; Moni MA; Saleh MA
Sci Rep; 2021 Jul; 11(1):15431. PubMed ID: 34326355
[TBL] [Abstract][Full Text] [Related]
37. The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain.
Wu J; Nie J; Zhang L; Song H; An Y; Liang Z; Yang J; Ding R; Liu S; Li Q; Li T; Cui Z; Zhang M; He P; Wang Y; Qu X; Hu Z; Wang Q; Huang W
Signal Transduct Target Ther; 2022 Jan; 7(1):18. PubMed ID: 35046385
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
Elife; 2022 Jan; 11():. PubMed ID: 35072628
[TBL] [Abstract][Full Text] [Related]
39. Exploring SARS-COV-2 structural proteins to design a multi-epitope vaccine using immunoinformatics approach: An in silico study.
Sanami S; Alizadeh M; Nosrati M; Dehkordi KA; Azadegan-Dehkordi F; Tahmasebian S; Nosrati H; Arjmand MH; Ghasemi-Dehnoo M; Rafiei A; Bagheri N
Comput Biol Med; 2021 Jun; 133():104390. PubMed ID: 33895459
[TBL] [Abstract][Full Text] [Related]
40. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
